Turkey's Changing Pharma Market Scene: What Opportunities For MNC Drug Makers?
This article was originally published in PharmAsia News
Executive Summary
Situated in one of the globe's most active emerging markets, the Turkish pharmaceutical industry is undergoing fast changes, which could make or break major drug makers, according to Istanbul-based international consulting firm Egon Zehnder International
You may also be interested in...
Nycomed Expands In Turkey, Despite Tough Pharma Environment
Swiss pharmaceutical manufacturer Nycomed has acquired rights from specialty pharmaceutical company Biomeks Ilac (Biomeks) to market a portfolio of over ten pharmaceutical products in Turkey
Nycomed Expands In Turkey, Despite Tough Pharma Environment
Swiss pharmaceutical manufacturer Nycomed has acquired rights from specialty pharmaceutical company Biomeks Ilac (Biomeks) to market a portfolio of over ten pharmaceutical products in Turkey
Nycomed Expands In Turkey, Despite Tough Pharma Environment
Nycomed has gained the rights to market over 10 pharmaceutical products in Turkey, consolidating its position in the country and keeping to its strategy of growth in pharmerging markets.